BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33482676)

  • 21. DVT incidence and risk factors in critically ill patients with COVID-19.
    Chen S; Zhang D; Zheng T; Yu Y; Jiang J
    J Thromb Thrombolysis; 2021 Jan; 51(1):33-39. PubMed ID: 32607652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
    Violi F; Ceccarelli G; Cangemi R; Cipollone F; D'Ardes D; Oliva A; Pirro M; Rocco M; Alessandri F; D'Ettorre G; Lichtner M; Pignatelli P; Ferro D; Ruberto F; Lip GYH; Pugliese F; Mastroianni CM;
    Intern Emerg Med; 2021 Aug; 16(5):1231-1237. PubMed ID: 34218413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Features of Venous Thromboembolism in Patients With Coronavirus Disease 2019 (COVID-19) in Japan - A Case Series Study.
    Yamashita Y; Hara N; Obana M; Ikeda S; Furuichi M; Ishiguro S; Iwai T; Kobayashi T; Mo M; Yamada N
    Circ J; 2021 Feb; 85(3):309-313. PubMed ID: 33473096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
    Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
    Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Nauka PC; Baron SW; Assa A; Mohrmann L; Jindal S; Oran E; Glazman-Kuczaj G; Southern WN; Chekuri S
    Thromb Res; 2021 Mar; 199():82-84. PubMed ID: 33476901
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.
    Billett HH; Reyes-Gil M; Szymanski J; Ikemura K; Stahl LR; Lo Y; Rahman S; Gonzalez-Lugo JD; Kushnir M; Barouqa M; Golestaneh L; Bellin E
    Thromb Haemost; 2020 Dec; 120(12):1691-1699. PubMed ID: 33186991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID).
    Lemos ACB; do Espírito Santo DA; Salvetti MC; Gilio RN; Agra LB; Pazin-Filho A; Miranda CH
    Thromb Res; 2020 Dec; 196():359-366. PubMed ID: 32977137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study on the impact of congenital thrombophilia in COVID-19.
    de la Morena-Barrio ME; Bravo-Pérez C; de la Morena-Barrio B; Orlando C; Cifuentes R; Padilla J; Miñano A; Herrero S; Marcellini S; Revilla N; Bernal E; Gómez-Verdú JM; Jochmans K; Herranz MT; Vicente V; Corral J; Lozano ML
    Eur J Clin Invest; 2021 May; 51(5):e13546. PubMed ID: 33738814
    [No Abstract]   [Full Text] [Related]  

  • 31. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study.
    Belcaro G; Corsi M; Agus GB; Cesarone MR; Cornelli U; Cotellese R; Feragalli B; Hu S
    Minerva Med; 2020 Aug; 111(4):366-368. PubMed ID: 33032396
    [No Abstract]   [Full Text] [Related]  

  • 33. Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports.
    Fatimazahra M; Harras ME; Bensahi I; Kassimi M; Oualim S; Elouarradi A; Abdeladim S; Sabry M
    J Thromb Thrombolysis; 2021 Aug; 52(2):493-496. PubMed ID: 33788160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
    Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
    Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
    [No Abstract]   [Full Text] [Related]  

  • 35. Wells Score to Predict Pulmonary Embolism in Patients with Coronavirus Disease 2019.
    Kirsch B; Aziz M; Kumar S; Burke M; Webster T; Immadi A; Sam M; Lal A; Estrada-Y-Martin RM; Cherian S; Aisenberg GM
    Am J Med; 2021 May; 134(5):688-690. PubMed ID: 33316254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin.
    Maurice-Dror C; Litvak M; Keren-Politansky A; Ackerman S; Haim N; Nadir Y
    J Thromb Thrombolysis; 2020 Jul; 50(1):112-122. PubMed ID: 32377957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Pancani R; Villari L; Foci V; Parri G; Barsotti F; Patrucco F; Malerba M; Vincenti R; Carrozzi L; Celi A
    Thromb Res; 2021 Jan; 197():44-47. PubMed ID: 33181470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.
    Chibane S; Gibeau G; Poulin F; Tessier P; Goulet M; Carrier M; Lanthier S
    J Thromb Thrombolysis; 2021 Jan; 51(1):25-28. PubMed ID: 32506364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis.
    Campello E; Bulato C; Spiezia L; Boscolo A; Poletto F; Cola M; Gavasso S; Simion C; Radu CM; Cattelan A; Tiberio I; Vettor R; Navalesi P; Simioni P
    Clin Chem Lab Med; 2021 Jun; 59(7):1323-1330. PubMed ID: 33544518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
    Kollias A; Kyriakoulis KG; Syrigos NK; Stergiou GS
    Thromb Res; 2021 Mar; 199():19-20. PubMed ID: 33385796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.